Clinical Trial Update: Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression [Phase 2]

View source ↗

Summary

Phase 2 study investigating niraparib rechallenge after surgery in ovarian cancer patients with oligometastatic progression; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Disease
• Ovarian Cancer
• Serous Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: MedSIR | Conditions: Ovarian Cancer, Oligometastatic Disease | Phase 2 | Status: RECRUITING